Login / Signup

The BLOODSAFE program: Building the future of access to safe blood in Sub-Saharan Africa.

Meghan DelaneySusan TelkeShimian ZouMakeda J WilliamsJackline O AridiKristina E RuddJuan Carlos PuyanaPratap KumarBernard AppiahYvonne Dei-AdomakohLucy Asamoah-AkuokoEdeghonghon OlayemiEmmanuel SingogoMina C HosseinipourBridon M'bayaEffie ChipetaCavan Reillynull nullRobert KamuJackline AridiAlejandro Munoz-ValenciaNakul RaykarLinda BarnesJennifer MakinBopaya BidandaMark H YazerJana MacLeodCarolyne Nkoki MuiriBernard OlayoGatwiri MurithiJayant RajgopalYiqi TianBo ZengTecla KivuliMuthoni MateAbdirahaman MusaCindy MicalHellen NyagolKevin OchiengTonny EpuuAmma Benneh-Akwasi KumaCatherine SegbefiaAlfred YawsonSeth Adu-AfarwuahPhillip AdongoMichael AcquahTara TancredEmmanuel Nene DeiImelda BatesSolomon Ofori-AcquahJustina Kordai AnsahDilys John-TeyeClaudia CohnHaitao ChuAdam BurnsMitch CroalKate EckrothCollin Van RynTitus ChiwindoVictor MwapasaAdamson MuulaPatani MhangoPrincess KayiraAndrew LikakaWilfred DzamaNatasha NsamalaGeoffrey KadewereMartias Joshua
Published in: Transfusion (2022)
Together the project teams and the DCC work as a consortium to support each other through a shared study protocol that will study donor motivations, outcomes, and adverse events across all three countries. The BLOODSAFE Program has the potential to lead to generalizable improvement approaches for increasing access to safe blood in SSA as well as mentoring and building the research capacity and careers of many investigators.
Keyphrases
  • quality improvement
  • study protocol
  • randomized controlled trial
  • open label
  • metabolic syndrome
  • insulin resistance